HD-OPM Archive

Most popular posts 101–200

  1. Taurine deficiency may drive aging; Columbia study spans worms, mice, monkeys and humans

    Mar 01, 2024 · Louis Nervegna ♥ 23 · 💬 28 ↩ 4 Aging & longevity

    Louis highlights a 2023 Columbia University study on taurine and aging in worms, mice, monkeys and humans, noting taurine also benefits the cardiovascular system. He stresses that age is the biggest causal risk factor for heart disease and taurine might be an anti-aging intervention, with emphasis on 'might', and that it seems reasonably safe.

  2. Olive oil's brief FMD dip resembles exercise's transient, hormetic endothelial effect

    Jul 02, 2024 · Louis Nervegna ♥ 19 · 💬 25 ↩ 6 Blood vessels, circulation & endothelium

    Responding to Esselstyn's reliance on a short-term study of refined olive oil impairing endothelial function, the poster notes exercise causes the same transient dip followed by rebound. Quoted exercise physiology papers describe an immediate FMD nadir followed by normalization or supranormalization, and he says over 30 RCTs show olive oil improves FMD long term.

  3. Testosterone for anti-aging lacks proven longevity benefit; high levels tied to deaths

    Mar 23, 2024 · Louis Nervegna ♥ 13 · 💬 34 ↩ 1 Hormones, women's & men's health

    Louis warns that the only proven benefit of testosterone therapy is treating clinically diagnosed hypogonadism and no credible study shows longevity benefit. He cites data from 3,690 men aged 70-92 showing an inverse U-shaped relation between testosterone and mortality, with risk rising above an optimal level, plus animal studies showing androgens shorten and castration extends lifespan. The animal evidence and sex-difference argument are suggestive, not proof in humans.

  4. RCT: one dose of high-polyphenol EVOO raised FMD 4.8% in adults at risk for diabetes

    Mar 14, 2025 · Louis Nervegna ♥ 20 · 💬 22 ↩ 5 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

    Louis rebuts Caldwell Esselstyn's claim that EVOO impairs endothelial function, citing a randomized crossover trial in adults at risk for type 2 diabetes. A single 50 mL dose of high-polyphenol EVOO improved flow-mediated dilation compared with refined olive oil, with no acute blood pressure effect, and the authors note that reports should specify the oil's characteristics.

  5. A cheaper high-polyphenol cocoa extract alternative to CocoaVia

    Dec 10, 2025 · Louis Nervegna ♥ 25 · 💬 36 Supplements & vitamins

    Louis shares a UK user's comparison of a bulk cacao extract (20:1) with CocoaVia's CocoaPro (24:1). The poster calculates that 1.5 g should provide about 500 mg cocoa flavanols, though the supplier does not test flavanol or epicatechin content directly. It is a consumer tip rather than evidence.

  6. Six non-diabetes benefits of metformin shown in trials, and the TAME aging hypothesis

    Aug 24, 2024 · Louis Nervegna ♥ 20 · 💬 29 Aging & longevity

    The post lists six effects of metformin reported in randomized trials of non-diabetics (long Covid, Covid outcomes, periodontal disease, muscle loss, knee osteoarthritis pain, oral pre-cancer lesions) and argues they share aging as a risk factor. It mentions a monkey study and the planned TAME trial testing whether metformin slows aging; most evidence is linked via Facebook shares.

  7. Beef and whey raise insulin more than equal-calorie oatmeal, pasta or bread

    May 09, 2025 · Louis Nervegna ♥ 10 · 💬 41 Insulin resistance & diabetes

    Louis explains that CGMs measure glucose, not insulin, and that some proteins provoke as much or more insulin than carbohydrates. Citing the 1997 insulin index paper and a 2012 whey study, he shows beef raises insulin more than pasta or oatmeal calorie for calorie, and whey more than glucose or white bread, so swapping protein for carbs may raise post-meal insulin.

  8. Humming boosts nasal nitric oxide about 15-fold; a small RCT hints at lower blood pressure

    Oct 19, 2025 · Louis Nervegna ♥ 28 · 💬 20 Blood pressure, salt & potassium

    Louis fact-checks a viral claim that humming raises nitric oxide 1400%: that equals about a 15-fold rise in nasal production (not 'brain' production as the post said), a finding from Weitzberg's 2002 work. A small randomized trial of bee-humming breathing in hypertension suggests blood pressure may fall, though whether nitric oxide is the mechanism is unclear.

  9. Berberine lowered plaque score 3.2% and TMAO in a small 21-patient trial

    Jun 10, 2024 · Louis Nervegna ♥ 18 · 💬 23 Gut microbiome

    Louis highlights a small human trial in which berberine reduced atherosclerotic plaque score, with a proposed mechanism of lowering gut-derived TMAO by acting on TMAO-producing gut bacteria. The sample is small and the comparison group was not randomized to the same degree as a large trial, so this is hypothesis-generating.

  10. Case report: 10 mg atorvastatin cleared most of a severe LAD blockage over 4 years

    Oct 06, 2025 · Louis Nervegna ♥ 29 · 💬 14 Statins

    Responding to influencers who say plaque cannot be reversed with statins, Louis cites a case report in which a patient taking low-dose atorvastatin went from a severe to a mild LAD narrowing, documented on CT angiography. It is a single case, but illustrates that statin-associated plaque regression can occur.

  11. Keto-CTA (LMHR): very high LDL keto dieters with plaque kept progressing despite lean

    Apr 07, 2025 · Louis Nervegna ♥ 14 · 💬 23 ↩ 1 Low-carb, keto & carnivore

    Louis summarizes the newly published one-year prospective Keto-CTA study of lean, metabolically healthy people on keto with very high LDL (mean 254 mg/dL). Those with baseline plaque progressed significantly at similar rates regardless of how high the LDL was, while those with zero plaque were unlikely to develop it within a year. There was no low-LDL comparison group.

  12. Full-fat yogurt lowered ApoB while yogurt with butter raised it in a crossover trial

    Apr 02, 2025 · Louis Nervegna ♥ 17 · 💬 24 Meat, eggs & dairy

    Louis summarizes a randomized crossover study that matched saturated fat in full-fat yogurt versus low-fat yogurt mixed with butter for 4 weeks each. The butter version raised ApoB while full-fat yogurt lowered it, which the authors attribute to the milk fat globule membrane (MFGM) that stays intact in yogurt but is lost in butter. This may partly explain yogurt's favorable epidemiology.

  13. Taurine and cardiovascular disease: anti-inflammatory and vascular effects

    Jan 27, 2024 · Gokhan Can ♥ 21 · 💬 26 ↩ 2 Supplements & vitamins

    A long evidence summary on taurine: deficiency causes cardiomyopathy in cats and in humans with transporter defects, higher taurine intake correlates with lower coronary disease, and animal studies show reduced atherosclerosis and vessel relaxation. The author is considering a supplement against chronic inflammation; most evidence cited is animal or observational.

  14. PCSK9 gene-editing therapy may not be safe yet; patient deaths occurred in a trial

    Mar 18, 2025 · Louis Nervegna ♥ 22 · 💬 24 PCSK9, ezetimibe & newer drugs

    Louis warns that experimental PCSK9 gene therapies for lowering LDL may be unsafe because people have died in trials, and notes that safe, effective drugs already exist, including PCSK9 inhibitors. He clarifies that the deaths were specific to the gene therapy in that trial, with unclear cause, and were not seen in long PCSK9 inhibitor drug trials.

  15. All 25 statin RCTs through 2016 show benefit: about 40% less MACE per 75 mg/dL LDL drop

    May 11, 2025 · Louis Nervegna ♥ 25 · 💬 12 Statins

    Louis shares a graph of every statin RCT up to 2016 that showed a significant effect on cardiovascular outcomes, excluding trials under 6 months or with under 50 events. On average, a ~75 mg/dL (1.9 mmol/L) LDL reduction cut heart attack and stroke risk about 40% vs placebo, with primary-prevention trials showing even larger reductions than secondary-prevention trials.

  16. Dr Carvalho: evidence for vitamin K2 supplements and arterial calcium is weak

    Nov 16, 2025 · Gokhan Can ♥ 19 · 💬 27 Supplements & vitamins

    Summarises a Carvalho video: arterial calcium is a marker of long-standing plaque, not the cause of risk, so lowering a calcium score can mislead, just as statins raise calcium while lowering risk. No large properly powered trials show K2 reduces heart attacks or strokes, and he warns of false reassurance. The admin adds that supplement use is fine but expectations should stay grounded.

  17. Esselstyn's plant-based diet is supported only by case series, not high-level evidence

    Nov 11, 2025 · Louis Nervegna ♥ 23 · 💬 22 ↩ 2 Mediterranean, DASH, MIND & plant-forward diets

    Louis argues the Esselstyn diet is probably healthy and likely lowers cardiovascular risk, but that claims for it are overhyped. Esselstyn's published work consists of case reports and case series, which sit low on the evidence hierarchy, so the strong evidence for plant-based diets in general should be allowed to speak for itself.

  18. Insulin stimulates liver cholesterol production, linking insulin resistance to high LDL

    Jun 25, 2024 · Louis Nervegna ♥ 17 · 💬 22 LDL, ApoB & lipid panel

    The post explains that insulin signals the liver to make more cholesterol by keeping HMG-CoA reductase active, one reason insulin resistance and metabolic syndrome go with high cholesterol. It argues protein, especially animal protein, also raises insulin, partly offset by glucagon, and that swapping animal for plant protein lowers cholesterol beyond saturated fat and fiber effects. Much of the protein argument is the poster's inference.

  19. Statin plaque regression RCTs: SATURN, REVERSAL, ASTEROID, COSMOS, JAPAN-ACS

    Jan 18, 2025 · Louis Nervegna ♥ 10 · 💬 29 ↩ 9 Plaque, CAC & CT angiography

    Louis lists human trials in which statins reversed or halted atheroma growth measured as percent atheroma volume (PAV). High-dose atorvastatin and rosuvastatin regressed PAV in SATURN and ASTEROID, while REVERSAL showed halted progression versus pravastatin. COSMOS added canakinumab to rosuvastatin, and PROSPECT and JAPAN-ACS showed lower progression on statins.

  20. Replacing saturated with polyunsaturated fat cut non-fatal heart attacks 25%

    Dec 16, 2025 · Louis Nervegna ♥ 15 · 💬 19 ↩ 1 Fats & oils (saturated fat, seed oils, omega-6, olive oil)

    Louis summarizes an Annals of Internal Medicine systematic review of 17 randomized trials with hard endpoints. Replacing saturated fat with polyunsaturated fat lowered non-fatal heart attacks by 25% in higher-risk people over 5 years, similar to a lower-dose statin; other outcomes trended favorably but were not fully significant when the replacement was the general diet.

  21. AHA now formally recommends resistance training to prevent heart disease

    Jan 01, 2024 · Louis Nervegna ♥ 18 · 💬 20 Exercise & fitness

    Louis highlights the American Heart Association's 2023 scientific statement updating its 2007 one on resistance training. It concludes resistance training, alone or with aerobic exercise, is safe and effective for improving cardiovascular health and risk factors in adults with and without cardiovascular disease.

  22. The longer the lower the better: lifelong LDL lowering and an estimated 60% risk reduction

    Nov 20, 2023 · Gokhan Can ♥ 17 · 💬 21 ↩ 2 LDL, ApoB & lipid panel

    Argues that the benefit of LDL lowering depends on both how much and how long LDL is reduced. The author, one of the group's admins, is betting on very low-dose statins to hold LDL at 70-100 mg/dL, and estimates about 60% lifetime risk reduction from a 70-point lowering sustained for 30 years. The post also cites Charles Grashow as a case of CAC regression.

  23. Novartis Lp(a)HORIZON: pelacarsen failed to reduce heart attacks and strokes

    Sep 04, 2026 · Louis Nervegna ♥ 20 · 💬 24 Lp(a)

    Louis shares the first outcome-trial result for an Lp(a)-lowering drug: topline data from Novartis say pelacarsen lowered Lp(a) but did not show reduced cardiovascular risk overall. He says the result seriously questions whether Lp(a) is directly causal, noting only a press announcement is available so far.

  24. A 1.1-4.7% absolute risk reduction from statins is large against a 20% lifetime risk

    Apr 28, 2024 · Louis Nervegna ♥ 14 · 💬 20 ↩ 2 Statins

    Louis explains relative versus absolute risk in statin trials. Statins cut absolute heart attack or stroke risk by 1.1% to 4.7% in roughly 5-year RCTs, which is large against a lifetime risk of about 20%, and sustained over decades could lower lifetime risk toward 10%. He shares a graph combining RCTs (over 20% risk reduction after 5 years), prospective cohorts (over 30% at 12 years) and Mendelian randomization (over 50% at 52 years) for a 39 mg/dL LDL reduction.

  25. Statins raise Lp(a) 5-20% yet still cut heart attack and stroke, including with high Lp(a)

    Jan 21, 2025 · Louis Nervegna ♥ 16 · 💬 22 Lp(a)

    Louis cites meta-analyses showing statins can raise Lp(a) by 5-20%, and a video of Stanford's Joshua Knowles explaining this is clinically unimportant and that statins are an important part of treating genetically high Lp(a). Across 25 statin trials, lowering LDL by about 75 mg/dL cut MACE roughly 40%, with larger relative reductions in primary prevention.

  26. Heart attack clots form on ruptured unstable plaque, not in plaque-free arteries

    Mar 17, 2025 · Louis Nervegna ♥ 29 · 💬 12 Heart attack, stroke & procedures

    Louis argues that although most heart attacks are caused by clots, clots form when unstable plaque ruptures, so people with near-zero plaque have near-zero risk of clot-caused heart attacks. Blood thinners like aspirin are proven to lower risk in people with considerable plaque but are unlikely to help, and may harm, those with little or no plaque.

  27. Daily peanuts raised brain blood flow about 4% in older adults, possibly via arginine

    Dec 03, 2025 · Louis Nervegna ♥ 27 · 💬 17 ↩ 2 Nuts, fish, coffee, tea, cocoa & other foods

    Louis shares a Clinical Nutrition study in which a daily 60 g serving of skin-roasted peanuts improved global brain blood flow by about 4% in older adults, roughly the decline seen over 10 years of aging. He suggests arginine-driven nitric oxide as the mechanism, and nuts as slow-release arginine that may also help heart health.

  28. Low-carb high-fat diet linked to higher LDL-C, ApoB and 2.18-fold MACE risk at 11.8 years

    May 04, 2024 · Louis Nervegna ♥ 11 · 💬 24 Low-carb, keto & carnivore

    Louis quotes a JACC: Advances cohort analysis comparing low-carbohydrate high-fat (LCHF) eaters with standard-diet controls. LCHF had significantly higher LDL-C and ApoB, more severe hypercholesterolemia, and more major adverse cardiovascular events at 11.8 years; the association remained after adjustment. People with a high LDL polygenic risk score had the highest LDL-C on LCHF.

  29. DISCO-CT: DASH diet plus statins reversed soft plaque by about 40 mm3 in a year

    Aug 18, 2025 · Louis Nervegna ♥ 22 · 💬 12 ↩ 25 Plaque, CAC & CT angiography

    Louis describes the DISCO-CT randomized trial, where a DASH-style diet with statins produced the largest soft plaque regression (NCPV) on CT angiography of any diet trial, -39.5 mm3 adjusted to one year. He puts this against about 5 mm3/year typical progression, with the caveat that this is relative to a typical American, not the patients' own history.

  30. Red yeast rice vs statins: lovastatin removed, other monacolins remain, no outcome RCTs

    Feb 11, 2024 · Louis Nervegna ♥ 22 · 💬 15 Supplements & vitamins

    Louis explains that the FDA forced US red yeast rice products to remove lovastatin (monacolin K), the first statin, approved in 1986 as Mevacor, yet they still lower cholesterol through related monacolins. Some people intolerant of statins tolerate it, but it is unregulated with variable potency and lacks large long-running RCTs proving fewer heart attacks and strokes, so it is a gamble for high-risk people.

  31. Johns Hopkins arginine RCT stopped early: 6 deaths vs 0 in heart-attack survivors

    Nov 29, 2023 · Louis Nervegna ♥ 13 · 💬 25 ↩ 3 Supplements & vitamins

    Louis warns that L-arginine supplements, taken to raise nitric oxide, can be dangerous after a heart attack. A Johns Hopkins randomized trial of 153 heart attack survivors given 3 g arginine three times daily was stopped after six months when six deaths occurred in the arginine group and none on placebo. Citrulline, which the body converts to arginine, might carry a similar concern, which is his speculation.

  32. Esselstyn's 'cure' angiogram overstates diet effect: baseline followed a heart attack

    Nov 13, 2026 · Louis Nervegna ♥ 19 · 💬 17 Mediterranean, DASH, MIND & plant-forward diets

    Louis critiques the angiogram of Esselstyn's patient Joseph Crowe, often cited as proof that diet cures heart disease. The baseline image came directly after a heart attack and showed plaque plus thrombus and vasospasm, so later opening of the artery reflects natural healing as well as diet. He also notes Crowe died at 72, about 28 years after a heart attack at 44.

  33. Three of 18 Seven Countries Study scientists who adopted a Mediterranean diet lived to 100

    Jun 02, 2025 · Louis Nervegna ♥ 15 · 💬 29 Mediterranean, DASH, MIND & plant-forward diets

    Louis shares an anecdote that 3 of the 18 scientists in the Seven Countries Study group, who personally switched to a traditional Mediterranean diet, reached age 100, including Ancel Keys at almost 101. He calculates the chance of this happening by chance at roughly 1 in 10 billion, versus about 1 in 10,000 Americans reaching 100; it is an anecdote, not a trial.

  34. Willett: refined starch and sugar (~40% of US calories) drive heart disease and diabetes

    Jan 26, 2024 · Louis Nervegna ♥ 14 · 💬 31 ↩ 26 Carbs, fiber, sugar & whole grains

    Louis argues that mainstream nutrition science now sees refined sugar and refined starch, possibly including white potatoes, as direct causes of heart disease and diabetes, citing Harvard's Walter Willett in a ZOE interview. He notes about 40% of US calories come from refined sugar/starch and white potatoes, and says this should be replaced with healthier carbohydrate or healthy fat and protein sources. The post is opinion backed by an expert interview, not a specific study.

  35. Lyon Diet Heart Study: Mediterranean diet cut cardiac events and deaths about 70%

    Dec 12, 2025 · Louis Nervegna ♥ 20 · 💬 16 Mediterranean, DASH, MIND & plant-forward diets

    Louis comments on a video clip about the Lyon Heart Study, a randomized secondary-prevention trial in people with a prior heart attack. The traditional Mediterranean diet cut cardiovascular events about 70% and all-cause death about 70% over 2.5 years, which he calls the largest total mortality reduction reported in a CVD prevention trial and about twice the benefit of statins in secondary prevention.

  36. The EWG 'Dirty Dozen' list ignores dose, and conventional produce is still good for you

    May 08, 2026 · Louis Nervegna ♥ 18 · 💬 24 Nuts, fish, coffee, tea, cocoa & other foods

    Louis argues the Dirty Dozen is built on flawed methodology (EWG weights all pesticides equally and ignores EPA safety thresholds). Decades of Harvard cohort data on conventionally grown produce show benefit, and a shared Barbell Medicine video says most exposures sit roughly a million times below safe reference doses.

  37. Full-fat yogurt lowered ApoB while low-fat yogurt plus butter raised it in a crossover RCT

    Jun 07, 2024 · Louis Nervegna ♥ 21 · 💬 15 ↩ 1 Meat, eggs & dairy

    Louis summarizes a randomized crossover trial matching saturated fat between full-fat yogurt and low-fat yogurt with added butter. Despite equal saturated fat, the butter arm raised ApoB while full-fat yogurt lowered it, which the study attributes to the milk fat globule membrane (MFGM) that is intact in yogurt but lost in butter. He suggests this may partly explain why yogurt looks better than other dairy in epidemiology.

  38. Exercise, including HIIT, can reduce coronary plaque burden and add to LDL lowering

    Jul 10, 2025 · Louis Nervegna ♥ 25 · 💬 17 ↩ 8 Plaque, CAC & CT angiography

    A shared review states that regular moderate-to-high intensity exercise reduces coronary plaque burden in CAD patients, with HIIT and moderate continuous training both leading to regression. Combining exercise with aggressive LDL control below 70 mg/dL gives additive benefit, while extreme volumes may increase calcification though with more stable plaque.

  39. Six RCTs show statins reverse total plaque volume by 5% to 17%

    Aug 25, 2026 · Louis Nervegna ♥ 27 · 💬 9 ↩ 1 Plaque, CAC & CT angiography

    Louis lists six randomized trials showing reversal of total atheroma volume with statins: COSMOS ~5%, SATURN ~5.5%, ASTEROID ~6.5%, IBIS-4 ~7.5%, STABLE ~8%, JAPAN-ACS ~17%. Reversals were measured by CT angiography or IVUS and came from soft rather than calcified plaque. A shared chart relates LDL to TAV change across statin, PCSK9 and ezetimibe trials.